Berry Street Capital Management LLP Vertex Pharmaceuticals Inc Transaction History

Berry Street Capital Management LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $2.77 Million - $3.26 Million	-12,500 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $2.21 Million - $2.79 Million	12,500 New	12,500 $2.75 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $2.27 Million - $2.54 Million	-12,500 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $3.28 Million - $3.87 Million	-17,500 Reduced 58.33%	12,500 $2.52 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $6.21 Million - $7.24 Million	30,000 New	30,000 $6.45 Million

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Berry Street Capital Management LLP, based on Form 13F filings with the SEC.

Stay updated on Berry Street Capital Management LLP with notifications on news.